Park Medi World reported a 19% rise in revenue to Rs 475.7 crore and a 42% jump in net profit for the June 2026 quarter. The company is actively executing an expansion plan to add 1,490 beds in 2026, including new facilities in Rudrapur and Zirakpur. While analysts are positive about this growth, investors should track margin volatility from ramp-up costs and the lack of dividends.
Park Medi World has posted a strong start to the 2027 fiscal year, reporting robust growth in both revenue and profit for the April-June quarter. The company’s consolidated revenue climbed 19% year-on-year to Rs 475.7 crore, up from Rs 399 crore in the same period last year. Net profit saw a sharper increase of 42%, reaching Rs 82.5 crore, driven by improved operational performance and a favorable case mix.
Expanding Hospital Network
The company is in the middle of an aggressive growth phase. It plans to add approximately 1,490 new beds during the calendar year 2026. Key recent developments include the acquisition of hospitals in Zirakpur, near the existing Mohali facility, and the ongoing ramp-up of new units in Panchkula, Rudrapur, and Agra. This expansion is central to the company’s strategy to increase its presence in high-potential regions.
Brokerages have maintained a positive view on this expansion-led growth. Research firms like Emkay Global Financial Services and Choice Institutional Equities have reiterated their 'Buy' ratings, projecting upside potential for the stock based on future earnings estimates. These projections rely on the assumption that as the new facilities stabilize, the hospital chain will see better utilization and profitability.
Financial and Operational Watchlist
While the headline numbers are strong, investors should look beyond the profit growth. The hospital sector typically faces high initial costs when starting new units. Some quarterly reports have noted a slight contraction in operating margins (EBITDA margins) on a quarter-on-quarter basis, partly due to the costs associated with ramping up new beds. Future profitability will depend on how quickly these new units can start contributing to the bottom line.
Additionally, the company’s tax profit in recent quarters has been supported by specific benefits, such as deferred tax credits. These are one-time or non-recurring in nature, meaning investors should keep an eye on operational margins rather than just relying on net profit figures. Furthermore, the company does not currently pay dividends, as it directs available cash toward capital spending and debt reduction. Maintaining a healthy balance sheet remains a priority for the management, and the current strategy focuses on balancing expansion with financial stability.